CUHK_CCT00279
2010-12-22
Prospective
Nil
Departmental research funding
Urology Division, Department of Surgery, CUHK
Nil
Lee, Wai Man
4/F, Department of Surgery, Clinical Science Building, PWH
26321663
kimlwm@surgery.cuhk.edu.hk
Urology Division, Department of Surgery, CUHK
Prof. Ng, Chi Fai
4/F, Department of Surgery, Clinical Science Building, PWH
26322625
ngcf@surgery.cuhk.edu.hk
Urology Division, Department of Surgery, CUHK
A prospective randomized double-blinded placebo controlled study on the effects of adjuvant tamsulosin OCAS in the treatment outcome of patient receiving extracorporeal shock wave lithotripsy for renal calculi
A prospective randomized double-blinded placebo controlled study on the effects of adjuvant tamsulosin OCAS in the treatment outcome of patient receiving extracorporeal shock wave lithotripsy for renal calculi
Tamsulosin After Lithotripsy to Kidney stone (TALK) trial
Hong Kong
Yes
2010-09-07
Renal Stone
Drug
Tamsulosin OCAS
12 weeks
Placebo
• Adult patient (aged ≥ 18 years old).
• Solitary radio-opaque renal stones of size 5-15 mm in maximal diameter as measured from plain radiography
• Clinically decided for primary ESWL
• Stones associated with any renal or ureteric anatomical abnormality, such as caliceal diverticulum, horseshoe kidney, ureteropelvic junction obstruction etc
• Patients with ureteric stent or nephrostomy tube inserted
• Patients with known history of cystine stone.
• Patients with multiple stones in the same calix
• Patient with history of allergy or any abnormal reaction alfentanil
18
Nil
Both Male and Female
Interventional
Randomized
Placebo
Double-blind
Parallel
2011-02-01
220
Unknown
Successful treatment - Defined as either stone free or presence of clinically insignificant residual fragments (less than 4mm) at 12 weeks after one session of lithotripsy.
Analgesics demand after treatment, maximal pain occurred after SWL, time to stone passage, stone free rate
2015-07-06
ChiCTR-TRC-10001135
2011-01-01
Yes
Nil
|
|
|
|
|
---|---|---|---|---|
No documents yet. |